Bio-Works forms distinguished Scientific Advisory Board
Bio-Works establishes a Scientific Advisory Board of leading experts to guide its research and product development strategy.
WorkBeads used for full scale production of FDA approved drug
Bio-Works' WorkBeads resins are used in full-scale commercial production of an FDA-approved biopharmaceutical, validating the product's quality and reliability.
Bio-Works opens sales office in USA
Press release March 20th 2018 Bio-Works has opened a sales office in Philadelpia, USA to [...]
Bio-Works secures another order from PolyPeptide
Press release Februari 23 2018 Bio-Works has received an order of 1,0 million SEK from [...]
Bio-Works säkrar ytterligare en order från PolyPeptide
Pressmeddelande den 23 februari 2018, kl: 07:37 Bio-Works har erhållit en order värd 1,0 miljon [...]
Interview with Dr. Yong Chul Shin, CEO of Amicogen Inc.
Amicogen Inc. is the largest shareholder in Bio-Works Technologies AB as of today, with slighty [...]
Prospekt i samband med börsintroduktion på Nasdaq First North
Bio-Works offentliggör prospekt inför listning på Nasdaq First North […]
Bio-Works strengthens the management with Mats Johnson as new CEO
Mats Johnson will from today, August 1 2017, take over the responsibility as CEO for [...]
Bio-Works Technologies AB New Share Issue Fully Subscribed
Bio-Works Technologies AB is pleased to announce that its recent new share issue has been [...]
Bio-Works Technologies AB awarded Vinnova grant
Bio-Works Technologies AB has been awarded over 1.5M SEK by Vinnova, the Swedish grant authority, to develop [...]
